Journal article
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
Nature communications, Vol.5(1), pp.3856-3856
2014
DOI: 10.1038/ncomms4856
PMCID: PMC4055950
PMID: 24920014
Abstract
Recent genome-wide association studies (GWAS) of Hodgkin lymphoma (HL) have identified associations with genetic variation at both HLA and non-HLA loci; however, much of heritable HL susceptibility remains unexplained. Here we perform a meta-analysis of three HL GWAS totaling 1,816 cases and 7,877 controls followed by replication in an independent set of 1,281 cases and 3,218 controls to find novel risk loci. We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio (OR) = 0.81, 95% confidence interval (95% CI) = 0.76-0.86, P-combined 3.5 x 10(-10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B-and T-cell lineage commitment known to be involved in HL pathogenesis. This meta-analysis also notes associations between previously published loci at 2p16, 5q31, 6p31, 8q24 and 10p14 and HL subtypes. We conclude that our data suggest a link between the 19p13.3 locus, including TCF3, and HL risk.
Details
- Title: Subtitle
- A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
- Creators
- W Cozen - University of Southern CaliforniaB. K Link - Carver College of Medicine, University of IowaM. N Timofeeva - International Agency for Research on CancerS Bhatia - City of Hope National Medical CenterJ. R Cerhan - Mayo ClinicD Li - Cedars-Sinai Medical CenterA Diepstra - University Medical Centre GroningenD Hazelett - University of Southern CaliforniaM Delahaye-Sourdeix - International Agency for Research on CancerC. K Edlund - University of Southern CaliforniaL Franke - University Medical Centre GroningenK Rostgaard - Statens seruminstitutD. J Van Den Berg - University of Southern CaliforniaV. K Cortessis - University of Southern CaliforniaK. E Smedby - Karolinska Institutet [Stockholm]S. L Glaser - Cancer Prevention Institute of CaliforniaH. -J Westra - University Medical Centre GroningenA. E Hwang - University of Southern CaliforniaL. L Robison - St Jude Children's Research HospitalS De Sanjose - Bellvitge Biomedical Research InstituteT. M Mack - University of Southern CaliforniaH Ghesquieres - Université Claude Bernard Lyon 1A Nieters - University of Freiburg [Freiburg]T Lightfoot - University of YorkN Becker - German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg]M Maynadié - Centre Hospitalier Universitaire de Dijon - Hôpital François MitterrandL Foretova - Masaryk Memorial Cancer InstituteE Roman - University of YorkY Benavente - Bellvitge Biomedical Research InstituteK. A Rand - University of Southern CaliforniaB. N Nathwani - City of Hope National Medical CenterB Glimelius - Uppsala UniversityA Staines - Dublin City UniversityP Boffetta - Icahn School of Medicine at Mount Sinai [New York]L Kiemeney - Radboud university [Nijmegen]S. M Ansell - Mayo ClinicL. C Strong - University of TexasPilar Galan - Centre de Recherche Épidémiologie et Statistique Sorbonne Paris CitéL Vatten - Norwegian University of Science and TechnologyT. M Habermann - Mayo ClinicE. J Duell - Bellvitge Biomedical Research InstituteA Lake - University of GlasgowR. N Veenstra - University Medical Centre GroningenL Visser - University Medical Centre GroningenY Liu - University Medical Center GroningenK. Y Urayama - Tokyo Medical and Dental UniversityD Montgomery - University of GlasgowV Gaborieau - International Agency for Research on CancerL. M Weiss - Clarient Pathology ServicesG Byrnes - International Agency for Research on CancerM Lathrop - Genome QuébecP Cocco - University of CagliariT Best - University of ChicagoA. D Skol - University of ChicagoH. -O Adami - Harvard University [Cambridge]M Melbye - Statens seruminstitutA Gallagher - University of GlasgowG. M Taylor - School of Cancer SciencesS. L Slager - Mayo ClinicP Brennan - International Agency for Research on CancerG. A Coetzee - University of Southern CaliforniaD. V Conti - University of Southern CaliforniaK Onel - University of ChicagoR. F Jarrett - Centre for Virus ResearchH Hjalgrim - Statens seruminstitutA Van Den Berg - University Medical Centre GroningenJ. D Mckay - International Agency for Research on Cancer
- Resource Type
- Journal article
- Publication Details
- Nature communications, Vol.5(1), pp.3856-3856
- DOI
- 10.1038/ncomms4856
- PMID
- 24920014
- PMCID
- PMC4055950
- NLM abbreviation
- Nat Commun
- ISSN
- 2041-1723
- eISSN
- 2041-1723
- Publisher
- Nature Publishing Group
- Language
- English
- Date published
- 2014
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
- Record Identifier
- 9984094352702771
Metrics
24 Record Views